Burn wounds: microbiology, local host defenses, and current therapy.
D000287:Administration, Topical; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents; D002056:Burns / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D002175:Candida / Q000302:isolation & purification; D003428:Cross Infection; D006084:Graft Rejection; D006097:Granulation Tissue / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007962:Leukocytes / Q000276:immunology; D009130:Muscle, Smooth / Q000473:pathology; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000473:pathology; D051381:Rats; D012706:Serratia marcescens / Q000302:isolation & purification; D016038:Skin Transplantation; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D014182:Transplantation, Autologous; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014946:Wound Infection / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents